“Lucigen Corporation and Research Corporation Technologies (RCT) today announced a partnership to commercialize and distribute the CleanColi^™ Expression System, the first Escherichia coli (E. coli)-based recombinant system that lacks unwanted endotoxin. Lucigen will produce and sell kits containing CleanColi^™ competent cells and provide contract research services for the CleanColi^™ Expression System. Lucigen simultaneously announces the release of a CleanColi^™ competent cell line enabling the production of proteins virtually free of endotoxin contamination, thereby minimizing purification and allowing faster and more accurate screening of biological targets for drug discovery research. Under the partnership, RCT will be responsible for the CleanColi^™ commercial licensing programs.”

About Lucigen Corporation

Located in Middleton, Wis., Lucigen delivers advanced molecular biology products and services to life scientists by inventing solutions to the most difficult problems in DNA cloning, amplification, protein expression, and next generation sequencing. With a focus on simplifying genomic research, Lucigen offers a wide selection of cloning kits, competent cells, and enzymes that enable scientists to quickly and easily complete even the most challenging molecular biology experiments.

Read more at Business Wire.

Mark Wilson, TermSync’s CEO, is interviewed by the Wisconsin State Journal

“[I]t’s a product we sell to companies to manage their receivables but the reason it works so well is all the benefits it gives their customers who are oftentimes small- and medium-sized businesses. So it’s a high volume of invoices, oftentimes smaller dollar amounts or low-margin invoices. One of our best clients is a large Midwest Pepsi distributor. They’re selling into restaurants, convenience stores and grocery stores. They’re delivering, sometimes, several times a week. That’s lots of invoices, but it helps organize that a lot better.”

Read more at the Wisconsin State Journal.

Venture Management, LLC lead a $1.05 million Series A investment round for Madison-based Swallow Solutions, LLC

Based on the research of UW-Madison School of Medicine professor JoAnne Robbins, Swallow Solutions has developed the MOST, or Madison Oral Strengthening Therapeutic device, a mouthpiece with sensors that connects to a computer. It is aimed at assessing and strengthening muscles used for swallowing.

Read more at the Wisconsin State Journal.

A Chicago Business Journal article explains how Chromatin is improving ethanol production in California:

Chromatin Inc., a developer of crop breeding technology, has agreed to help Californian ethanol producer Calgren Renewable Fuels develop a local supply chain for sorghum used in the production of fuel ethanol and distiller’s grains.

Read more at BizJournals.com.

An article in the Milwaukee Journal Sentinel details how GreenWhey will open a food-waste processing and conversion site near Eau Claire, WI:

The anaerobic digester will be among the largest privately held wastewater treatment facilities producing energy in the country. The project is moving forward after obtaining construction and long-term financing, according to GreenWhey Energy, which was formed to build and operate the digester.

Read more at JSOnline.com.

A Milwaukee Journal Sentinel article highlights how VMLLC investment Kayo Technologies is poised to revolutionize physical therapy:

The Madison company says the device, which attaches to resistance bands, helps physical therapists precisely measure and chart the amount of pressure from a patient’s exercise. Then, it transfers the data to computers, smartphones and electronic medical records.

Read more at JSOnline.com.